Orac has long argued that chelation therapy for heart disease is quackery. An abstract presented last month finally confirmed that. Why did it take so long?
Tag: Trial to Assess Chelation Therapy
Quackademic medicine. I didn’t invent the term. (Dr. R. W. Donnell did—nearly nine years ago.) However, I sure use it a lot, because it perfectly describes a phenomenon that has proliferated and metastasized throughout the body of academic medicine like the cancer it is. I like to think that, in my own way, I’ve popularized […]
Whenever I refer to quackademic medicine and how the infiltration of quackery into medical academia has led to unethical clinical that are not only pseudoscientific wastes of money but potentially downright harmful to patients, two always come to mind. The first is the trial that tested the late Nicholas Gonzalez’s protocol for advanced pancreatic cancer, […]
One of the things that first led me to understand the dangers of quackademic medicine was a trial known as the Trial to Assess Chelation Therapy, or TACT. Chelation therapy, as you might recall, is the infusion of a chelating agent, or a chemical that binds heavy metals and makes it easier for the kidney […]
Over the years, the criticism of “evidence-based medicine” (EBM) that I have repeated here and that I and others have repeated at my not-so-super-secret other blog is that its levels of evidence relegate basic science considerations to the lowest level evidence and elevate randomized clinical trial evidence to the highest rung, in essence fetishizing it […]